BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2874147)

  • 1. Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts.
    Massagué J; Kelly B
    J Cell Physiol; 1986 Aug; 128(2):216-22. PubMed ID: 2874147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling.
    Sathre KA; Tsang ML; Weatherbee JA; Steer CJ
    Hepatology; 1991 Aug; 14(2):287-95. PubMed ID: 1650327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the fate of receptor-bound 125I-interleukin 1 beta in porcine synovial fibroblasts.
    Bird TA; Saklatvala J
    J Immunol; 1987 Jul; 139(1):92-7. PubMed ID: 2953819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of interleukin 1 (IL 1) receptor expression by IL 1 and fate of internalized 125I-labeled IL 1 beta in a human large granular lymphocyte cell line.
    Matsushima K; Yodoi J; Tagaya Y; Oppenheim JJ
    J Immunol; 1986 Nov; 137(10):3183-8. PubMed ID: 2945861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
    Korc M; Haussler CA; Trookman NS
    Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular structures involved in internalization and degradation of epidermal growth factor.
    Fine RE; Goldenberg R; Sorrentino J; Herschman HR
    J Supramol Struct Cell Biochem; 1981; 15(3):235-51. PubMed ID: 6267315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the rebinding of 125I-epidermal growth factor released from BALB/c-3T3 cells following accumulation in the presence of chloroquine.
    Cooper JL; Wakshull E; Wharton W
    J Cell Physiol; 1988 Mar; 134(3):387-95. PubMed ID: 3258311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
    Keski-Oja J; Lyons RM; Moses HL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor.
    Jetten AM
    J Cell Physiol; 1982 Mar; 110(3):235-40. PubMed ID: 6282898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total cellular activity and distribution of a subpopulation of galactosyl receptors in isolated rat hepatocytes are differentially affected by microtubule drugs, monensin, low temperature, and chloroquine.
    McAbee DD; Lear MC; Weigel PH
    J Cell Biochem; 1991 Jan; 45(1):59-68. PubMed ID: 1848563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
    Piek E; Franzén P; Heldin CH; ten Dijke P
    J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling.
    Celada A; Schreiber RD
    J Immunol; 1987 Jul; 139(1):147-53. PubMed ID: 2953810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine allows the secretion of internalized 125I-epidermal growth factor from fibroblasts.
    Wakshull E; Cooper JL; Wharton W
    J Cell Physiol; 1985 Nov; 125(2):215-22. PubMed ID: 3877059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.
    Rook AH; Kehrl JH; Wakefield LM; Roberts AB; Sporn MB; Burlington DB; Lane HC; Fauci AS
    J Immunol; 1986 May; 136(10):3916-20. PubMed ID: 2871107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
    Carr BI; Hayashi I; Branum EL; Moses HL
    Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease nexins: cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases.
    Knauer DJ; Thompson JA; Cunningham DD
    J Cell Physiol; 1983 Dec; 117(3):385-96. PubMed ID: 6317700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts.
    Petridou S; Maltseva O; Spanakis S; Masur SK
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):89-95. PubMed ID: 10634606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequestration requirements for the degradation of 125I-labeled beta nerve growth factor bound to embryonic sensory neurons.
    Stach RW; Wagner BJ
    J Neurosci Res; 1982; 7(4):403-11. PubMed ID: 6292441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.